Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis

Nephrogenic Systemic Fibrosis Clinical Trial

Official title:
Validation of a Questionnaire as a Screening Tool to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis

Status Completed

Clinical Trial Summary

The Primary Aim of this study is to validate a questionnaire as a screening tool to identify subjects with symptoms suggestive of nephrogenic systemic fibrosis (NSF). The investigators believe that there will be difference between subjects with NSF and other skin conditions and normal skin.

Clinical Trial Description

n/a

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00869479
Study type	Observational
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	N/A
Start date	March 2009
Completion date	September 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00981942` - Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec	Phase 3
Completed	`NCT01135316` - Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR	N/A
Active, not recruiting	`NCT00677092` - Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis	Phase 2
Enrolling by invitation	`NCT01359345` - Nephrogenic Systemic Fibrosis With Gadollinum	Phase 2/Phase 3
Withdrawn	`NCT00811863` - Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection	N/A
Terminated	`NCT01078987` - Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)	Phase 4
Completed	`NCT01014754` - Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels	N/A